Vikas Kundra Selected Research

indium-111-octreotide

12/2016	Angiotensin II increases gene expression after selective intra-arterial adenovirus delivery in a rabbit model assessed using in vivo SSTR2-based reporter imaging.
10/2013	Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer.
3/2002	Noninvasive monitoring of somatostatin receptor type 2 chimeric gene transfer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vikas Kundra Research Topics

Disease

40	Neoplasms (Cancer) 01/2022 - 03/2002
10	Ovarian Neoplasms (Ovarian Cancer) 02/2021 - 06/2007
8	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2007
7	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2008
5	Carcinoma (Carcinomatosis) 08/2017 - 08/2006
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2015 - 10/2006
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2017 - 02/2014
2	Lung Neoplasms (Lung Cancer) 11/2015 - 10/2006
2	Carcinogenesis 11/2015 - 03/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2015 - 09/2009
1	Tuberculosis (Tuberculoses) 01/2022
1	Tuberous Sclerosis (Bourneville's Disease) 01/2022
1	Extranodal Extension 05/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Medulloblastoma 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Disease Progression 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Endometrial Neoplasms (Endometrial Cancer) 02/2016

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 02/2021 - 10/2006
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2006
4	somatostatin receptor 2IBA 09/2009 - 03/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 03/2006
3	Pharmaceutical PreparationsIBA 01/2020 - 04/2015
3	indium-111-octreotideIBA 12/2016 - 03/2002
3	Somatostatin Receptors (Somatostatin Receptor)IBA 10/2013 - 06/2005
3	Docetaxel (Taxotere)FDA Link 07/2012 - 10/2007
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 05/2021 - 09/2014
2	Coloring Agents (Dyes)IBA 02/2021 - 06/2017
2	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2015
2	AntigensIBA 01/2020 - 03/2009
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 08/2008
2	LigandsIBA 01/2020 - 06/2007
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 12/2011
2	Indicators and Reagents (Reagents)IBA 12/2017 - 01/2015
2	Phosphotransferases (Kinase)IBA 12/2017 - 03/2012
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2017 - 10/2007
2	Prostate-Specific Antigen (Semenogelase)IBA 08/2017 - 09/2014
2	PlatinumIBA 08/2017 - 07/2012
2	Green Fluorescent ProteinsIBA 12/2016 - 09/2009
2	Monoclonal AntibodiesIBA 09/2014 - 03/2006
2	CholesterolIBA 10/2013 - 10/2006
2	perifosineIBA 07/2012 - 12/2007
2	AndrogensIBA 03/2012 - 08/2008
2	ProdrugsIBA 01/2008 - 06/2007
1	trans-sodium crocetinate (crocetin)IBA 01/2022
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Fluorescent Dyes (Fluorescent Probes)IBA 05/2021
1	AntibodiesIBA 02/2021
1	bempegaldesleukinIBA 01/2021
1	RE1-silencing transcription factorIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 12/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 12/2017
1	Angiogenesis InhibitorsIBA 12/2017
1	CarbonIBA 12/2017
1	pazopanib FDA Link 12/2017
1	FluorineIBA 12/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2017
1	Pyruvic Acid (Pyruvate)IBA 12/2017
1	Capsid Proteins (Capsid Protein)IBA 06/2017
1	Capsules (Microcapsules)IBA 02/2017
1	Polytetrafluoroethylene (Teflon)FDA Link 02/2017
1	Dinoprostone (PGE2)FDA Link 11/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2015
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2015
1	15-keto-13,14-dihydroprostaglandin E2IBA 11/2015
1	human ERBB2 proteinIBA 10/2015
1	PBI-05204IBA 04/2015
1	Cardiac GlycosidesIBA 04/2015
1	Gemcitabine FDA Link 04/2015
1	oleandrinIBA 04/2015
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 09/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2014
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 09/2014
1	Epidermal Growth Factor (EGF)IBA 09/2014
1	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 10/2013

Therapy/Procedure

18	Therapeutics 01/2022 - 03/2006
4	Gamma Cameras (Gamma Camera) 12/2016 - 06/2005
3	Castration 01/2022 - 08/2008
3	Drug Therapy (Chemotherapy) 08/2017 - 10/2007
2	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 01/2020
1	Intraperitoneal Injections 05/2021
1	Cytoreduction Surgical Procedures 05/2021
1	Chemoradiotherapy 01/2021
1	Salvage Therapy 01/2020
1	Aftercare (After-Treatment) 12/2017
1	Hysterectomy 02/2016
1	Precision Medicine 09/2014
1	Phototherapy (Light Therapy) 09/2014